Ferdinand Ploner
Impact in
- Oncology top 5%
- Bone health and treatments
- Cancer Research top 10%
- Breast Cancer Treatment Studies
Papers in
- Oncology 11
- Cancer Treatment and Pharmacology 2
-
- Lung Cancer Treatments and Mutations 4
- Sarcoma Diagnosis and Treatment 3
- Co-authors
- Hellmut Samonigg (12 shared papers)Karl‐Walter Jauch (1 shared paper)Peter Reichardt (1 shared paper)Lars H. Lindner (1 shared paper)Soeren Daugaard (1 shared paper)Andrea Baur‐Melnyk (1 shared paper)Ulrich Mansmann (1 shared paper)Rolf D. Issels (1 shared paper)
- Journals
- PLoS ONE (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Breast Cancer Research and Treatment (2 papers)Lung Cancer (2 papers)The Lancet Oncology (2 papers)
- Partner nations
- AustriaUnited StatesGermany
In The Last Decade
Ferdinand Ploner
25 papers receiving 1.3k citations
Ferdinand Ploner's Hit Papers
Peers
Comparison fields: 5 of 94
- Oncology 489
- Cancer Research 157
- Orthopedics and Sports Medicine 78
- Pulmonary and Respiratory Medicine 270
- Radiology, Nuclear Medicine and Imaging 162
Countries citing papers authored by Ferdinand Ploner
This map shows the geographic impact of Ferdinand Ploner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ferdinand Ploner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ferdinand Ploner more than expected).
Fields of papers citing papers by Ferdinand Ploner
This network shows the impact of papers produced by Ferdinand Ploner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ferdinand Ploner. The network helps show where Ferdinand Ploner may publish in the future.
Co-authors
The 25 scholars most cited alongside Ferdinand Ploner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study Hit paper breakdown → | 2010 | 490 |
| 2 | 2008 | 282 | |
| 3 | 2006 | 157 | |
| 4 | 2008 | 93 | |
| 5 | 2006 | 40 | |
| 6 | 2017 | 33 | |
| 7 | 2014 | 32 | |
| 8 | 2002 | 31 | |
| 9 | 2007 | 30 | |
| 10 | 2008 | 29 | |
| 11 | 2013 | 21 | |
| 12 | 2004 | 20 | |
| 13 | 2004 | 16 | |
| 14 | 2014 | 13 | |
| 15 | 2013 | 10 | |
| 16 | 2012 | 9 | |
| 17 | 2007 | 9 | |
| 18 | 2010 | 9 | |
| 19 | 2015 | 9 | |
| 20 | 2011 | 8 |
About Ferdinand Ploner
Ferdinand Ploner is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Cancer Research and Molecular Biology, having authored 27 papers that have together received 1.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (4 papers), Sarcoma Diagnosis and Treatment (3 papers), Breast Cancer Treatment Studies (3 papers), Gastrointestinal Tumor Research and Treatment (3 papers), Soft tissue tumors and treatment (2 papers), Cancer Genomics and Diagnostics (2 papers), Cancer Treatment and Pharmacology (2 papers) and Breast Lesions and Carcinomas (2 papers). The work is most often cited by research in Oncology (489 citations), Cancer Research (157 citations), Orthopedics and Sports Medicine (78 citations), Pulmonary and Respiratory Medicine (270 citations) and Radiology, Nuclear Medicine and Imaging (162 citations). Ferdinand Ploner has collaborated with scholars based in Austria, United States and Germany. Frequent co-authors include Hellmut Samonigg, Karl‐Walter Jauch, Peter Reichardt, Lars H. Lindner, Soeren Daugaard, Andrea Baur‐Melnyk, Ulrich Mansmann, Rolf D. Issels, Jean‐Yves Blay and Jaap Verweij. Their work appears in journals such as PLoS ONE, Cancer Chemotherapy and Pharmacology, Breast Cancer Research and Treatment, Lung Cancer and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.